Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and fluvastatin upstream therapy in hypertension with non-permanent atrial fibrillation
ChiCTR-TRC-12002642Phase 4Completed
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of valsartan and fluvastatin in hypertension (HTN) and Atrial fibrillation (AFib) (4 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoints: Permanent atrial fibrillation and Persistent atrial fibrillation. Started Oct 2012; status: completed.
02
Drugs
valsartanfluvastatin
03
Conditions
hypertension (HTN)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR-TRC-12002642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002642.